Expression QTL mapping in regulatory and helper T cells from the BXD family of strains reveals novel cell-specific genes, gene-gene interactions and candidate genes for auto-immune disease

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Alberts, Rudi ^a   Chen, Hairong ^a   Pommerenke, Claudia ^a   Smit, August B ^d   Spijker, Sabine ^d   Williams, Robert W ^e   Geffers, Robert ^b   Bruder, Dunja ^b,c   Schughart, Klaus ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; NEUROPILIN 1; STAT3 PROTEIN; TRANSCRIPTOME; ZINC FINGER PROTEIN;

ALLERGY; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; CTLA4 GENE; F2RL1 GENE; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC REGULATION; HELPER CELL; HOMEOSTASIS; IKZF4 GENE; KLRB1F GENE; MOUSE; NONHUMAN; NRP1 GENE; QUANTITATIVE TRAIT LOCUS MAPPING; REGULATORY T LYMPHOCYTE; STAT3 GENE; ANIMAL; AUTOIMMUNE DISEASE; C57BL MOUSE; DBA MOUSE; GENETICS; METABOLISM; QUANTITATIVE TRAIT LOCUS;

ANIMALS; AUTOIMMUNE DISEASES; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; QUANTITATIVE TRAIT LOCI; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 83655182599     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-610     Document Type: Article

References (82)

1. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006, 212:8-27. 10.1111/j.0105-2896.2006.00427.x, 16903903.
2. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155(3):1151-1164.
3. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol 2004, 34(3):623-630. 10.1002/eji.200324799, 14991591.
4. Lechner O, Lauber J, Franzke A, Sarukhan A, von Boehmer H, Buer J. Fingerprints of anergic T cells. Curr Biol 2001, 11(8):587-595. 10.1016/S0960-9822(01)00160-9, 11369203.
5. Lehmann J, Huehn J, de la Rosa M, Maszyna F, Kretschmer U, Krenn V, Brunner M, Scheffold A, Hamann A. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc Natl Acad Sci USA 2002, 99(20):13031-13036. 10.1073/pnas.192162899, 130581, 12242333.
6. Lohning M, Hutloff A, Kallinich T, Mages HW, Bonhagen K, Radbruch A, Hamelmann E, Kroczek RA. Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med 2003, 197(2):181-193. 10.1084/jem.20020632, 2193816, 12538658.
7. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, Byrne MC. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002, 16(2):311-323. 10.1016/S1074-7613(02)00280-7, 11869690.
8. Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30(5):636-645. 10.1016/j.immuni.2009.04.010, 19464986.
9. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002, 3(2):135-142. 10.1038/ni759, 11812990.
10. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4(4):330-336. 10.1038/ni904, 12612578.
11. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299(5609):1057-1061. 10.1126/science.1079490, 12522256.
12. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007, 8(5):457-462. 10.1038/ni1455, 17440451.
13. Peirce JL, Lu L, Gu J, Silver LM, Williams RW. A new set of BXD recombinant inbred lines from advanced intercross populations in mice. BMC Genet 2004, 5:7. 420238, 15117419.
14. Taylor B. Recombinant inbred strains. Genetic Variation in the Laboratory Mouse 1989, 773-796. Oxford: Oxford University Press, Lyon ML, Searle AG.
15. Williams RW, Gu J, Qi S, Lu L. The genetic structure of recombinant inbred mice: high-resolution consensus maps for complex trait analysis. Genome Biol 2001, 2(11):RESEARCH0046. 59991, 11737945.
16. Bystrykh L, Weersing E, Dontje B, Sutton S, Pletcher MT, Wiltshire T, Su AI, Vellenga E, Wang J, Manly KF, et al. Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'. Nat Genet 2005, 37(3):225-232. 10.1038/ng1497, 15711547.
17. Boon AC, deBeauchamp J, Hollmann A, Luke J, Kotb M, Rowe S, Finkelstein D, Neale G, Lu L, Williams RW, et al. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol 2009, 83(20):10417-10426. 10.1128/JVI.00514-09, 2753106, 19706712.
18. Abdeltawab NF, Aziz RK, Kansal R, Rowe SL, Su Y, Gardner L, Brannen C, Nooh MM, Attia RR, Abdelsamed HA, et al. An unbiased systems genetics approach to mapping genetic loci modulating susceptibility to severe streptococcal sepsis. PLoS Pathog 2008, 4(4):e1000042. 10.1371/journal.ppat.1000042, 2277464, 18421376.
19. Miyairi I, Laxton JD, Wang X, Obert CA, Arva Tatireddigari VR, van Rooijen N, Hatch TP, Byrne GI. Chlamydia psittaci Genetic Variants Differ in Virulence by Modulation of Host Immunity. J Infect Dis 2011, 204(4):654-663. 10.1093/infdis/jir333, 21791668.
20. Chesler EJ, Lu L, Wang J, Williams RW, Manly KF. WebQTL: rapid exploratory analysis of gene expression and genetic networks for brain and behavior. Nat Neurosci 2004, 7(5):485-486. 10.1038/nn0504-485, 15114364.
21. Jansen RC, Nap JP. Genetical genomics: the added value from segregation. Trends Genet 2001, 17(7):388-391. 10.1016/S0168-9525(01)02310-1, 11418218.
22. Alberts R, Terpstra P, Bystrykh LV, de Haan G, Jansen RC. A statistical multiprobe model for analyzing cis and trans genes in genetical genomics experiments with short-oligonucleotide arrays. Genetics 2005, 171(3):1437-1439. 10.1534/genetics.105.045930, 1456841, 16079228.
23. Alberts R, Lu L, Williams RW, Schughart K. Genome-wide analysis of the mouse lung transcriptome reveals novel molecular gene interaction networks and cell-specific expression signatures. Respir Res 2011, 12:61. 10.1186/1465-9921-12-61, 3105947, 21535883.
24. Peidis P, Giannakouros T, Burow ME, Williams RW, Scott RE. Systems genetics analyses predict a transcription role for P2P-R: molecular confirmation that P2P-R is a transcriptional co-repressor. BMC Syst Biol 2010, 4:14. 10.1186/1752-0509-4-14, 2843647, 20184719.
25. Li Z, Mulligan MK, Wang X, Miles MF, Lu L, Williams RW. A transposon in comt generates mRNA variants and causes widespread expression and behavioral differences among mice. PLoS ONE 2010, 5(8):e12181. 10.1371/journal.pone.0012181, 2923157, 20808911.
26. Geisert EE, Lu L, Freeman-Anderson NE, Templeton JP, Nassr M, Wang X, Gu W, Jiao Y, Williams RW. Gene expression in the mouse eye: an online resource for genetics using 103 strains of mice. Mol Vis 2009, 15:1730-1763. 2736153, 19727342.
27. Mozhui K, Ciobanu DC, Schikorski T, Wang X, Lu L, Williams RW. Dissection of a QTL hotspot on mouse distal chromosome 1 that modulates neurobehavioral phenotypes and gene expression. PLoS Genet 2008, 4(11):e1000260. 10.1371/journal.pgen.1000260, 2577893, 19008955.
28. Koutnikova H, Laakso M, Lu L, Combe R, Paananen J, Kuulasmaa T, Kuusisto J, Haring HU, Hansen T, Pedersen O, et al. Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human genetics. PLoS Genet 2009, 5(8):e1000591. 10.1371/journal.pgen.1000591, 2715105, 19662162.
29. Poot M, Badea A, Williams RW, Kas MJ. Identifying Human Disease Genes through Cross-Species Gene Mapping of Evolutionary Conserved Processes. PLoS ONE 2011, 6(5):e18612. 10.1371/journal.pone.0018612, 3087714, 21572526.
30. Mountz JD, Yang P, Wu Q, Zhou J, Tousson A, Fitzgerald A, Allen J, Wang X, Cartner S, Grizzle WE, et al. Genetic segregation of spontaneous erosive arthritis and generalized autoimmune disease in the BXD2 recombinant inbred strain of mice. Scand J Immunol 2005, 61(2):128-138. 10.1111/j.0300-9475.2005.01548.x, 15683449.
31. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000, 192(2):303-310. 10.1084/jem.192.2.303, 2193248, 10899917.
32. Hansen W, Loser K, Westendorf AM, Bruder D, Pfoertner S, Siewert C, Huehn J, Beissert S, Buer J. G protein-coupled receptor 83 overexpression in naive CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo. J Immunol 2006, 177(1):209-215.
33. Solomon BD, Mueller C, Chae WJ, Alabanza LM, Bynoe MS. Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011, 108(5):2040-2045. 10.1073/pnas.1008721108, 3033275, 21245328.
34. Glinka Y, Stoilova S, Mohammed N, Prud'homme GJ. Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis 2011, 32(4):613-621. 10.1093/carcin/bgq281, 21186301.
35. Catalano A. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis. J Immunol 2010, 185(10):6373-6383. 10.4049/jimmunol.0903527, 20937848.
36. Glinka Y, Prud'homme GJ. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc Biol 2008, 84(1):302-310. 10.1189/jlb.0208090, 2504713, 18436584.
37. Sarris M, Andersen KG, Randow F, Mayr L, Betz AG. Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition. Immunity 2008, 28(3):402-413. 10.1016/j.immuni.2008.01.012, 2726439, 18328743.
38. Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007, 445(7130):936-940. 10.1038/nature05563, 17237761.
39. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, Kim H, Singh P, Lee A, Chen WV, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010, 466(7302):113-117. 10.1038/nature09114, 2921172, 20596022.
40. Bryceson YT, Rudd E, Zheng C, Edner J, Ma D, Wood SM, Bechensteen AG, Boelens JJ, Celkan T, Farah RA, et al. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 2007, 110(6):1906-1915. 10.1182/blood-2007-02-074468, 1976360, 17525286.
41. Macartney CA, Weitzman S, Wood SM, Bansal D, Steele M, Meeths M, Abdelhaleem M, Bryceson YT. Unusual functional manifestations of a novel STX11 frameshift mutation in two infants with familial hemophagocytic lymphohistiocytosis type 4 (FHL4). Pediatr Blood Cancer 2011, 56(4):654-657. 10.1002/pbc.22676, 21298754.
42. Ciobanu DC, Lu L, Mozhui K, Wang X, Jagalur M, Morris JA, Taylor WL, Dietz K, Simon P, Williams RW. Detection, validation, and downstream analysis of allelic variation in gene expression. Genetics 2010, 184(1):119-128. 10.1534/genetics.109.107474, 2802080, 19884314.
43. Kooij G, Backer R, Koning JJ, Reijerkerk A, van Horssen J, van der Pol SM, Drexhage J, Schinkel A, Dijkstra CD, den Haan JM, et al. P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS ONE 2009, 4(12):e8212. 10.1371/journal.pone.0008212, 2785479, 19997559.
44. Migliaccio AR, Rana RA, Sanchez M, Lorenzini R, Centurione L, Bianchi L, Vannucchi AM, Migliaccio G, Orkin SH. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med 2003, 197(3):281-296. 10.1084/jem.20021149, 2193836, 12566412.
45. Yamaguchi T, Miyashita C, Koyano S, Kanda H, Yoshioka K, Shiba T, Takamatsu N, Ito M. JNK-binding protein 1 regulates NF-kappaB activation through TRAF2 and TAK1. Cell Biol Int 2009, 33(3):364-368. 10.1016/j.cellbi.2009.01.003, 19385034.
46. Bowdish DM, Sakamoto K, Kim MJ, Kroos M, Mukhopadhyay S, Leifer CA, Tryggvason K, Gordon S, Russell DG. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 2009, 5(6):e1000474. 10.1371/journal.ppat.1000474, 2688075, 19521507.
47. Jozefowski S, Arredouani M, Sulahian T, Kobzik L. Disparate regulation and function of the class A scavenger receptors SR-AI/II and MARCO. J Immunol 2005, 175(12):8032-8041.
48. Rogers NJ, Lees MJ, Gabriel L, Maniati E, Rose SJ, Potter PK, Morley BJ. A defect in Marco expression contributes to systemic lupus erythematosus development via failure to clear apoptotic cells. J Immunol 2009, 182(4):1982-1990. 10.4049/jimmunol.0801320, 19201851.
49. Dahl M, Bauer AK, Arredouani M, Soininen R, Tryggvason K, Kleeberger SR, Kobzik L. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J Clin Invest 2007, 117(3):757-764. 10.1172/JCI29968, 1804372, 17332894.
50. Pei L, Castrillo A, Chen M, Hoffmann A, Tontonoz P. Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem 2005, 280(32):29256-29262. 10.1074/jbc.M502606200, 15964844.
51. McEvoy AN, Murphy EA, Ponnio T, Conneely OM, Bresnihan B, FitzGerald O, Murphy EP. Activation of nuclear orphan receptor NURR1 transcription by NF-kappa B and cyclic adenosine 5'-monophosphate response element-binding protein in rheumatoid arthritis synovial tissue. J Immunol 2002, 168(6):2979-2987.
52. Volakakis N, Joodmardi E, Perlmann T. NR4A orphan nuclear receptors influence retinoic acid and docosahexaenoic acid signaling via up-regulation of fatty acid binding protein 5. Biochem Biophys Res Commun 2009, 390(4):1186-1191. 10.1016/j.bbrc.2009.10.116, 19861119.
53. Kasper G, Vogel A, Klaman I, Grone J, Petersen I, Weber B, Castanos-Velez E, Staub E, Mennerich D. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression. Cancer Lett 2005, 224(1):93-103. 10.1016/j.canlet.2004.10.004, 15911104.
54. Schmidlin F, Amadesi S, Dabbagh K, Lewis DE, Knott P, Bunnett NW, Gater PR, Geppetti P, Bertrand C, Stevens ME. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 2002, 169(9):5315-5321.
55. Khoufache K, LeBouder F, Morello E, Laurent F, Riffault S, Andrade-Gordon P, Boullier S, Rousset P, Vergnolle N, Riteau B. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway. J Immunol 2009, 182(12):7795-7802. 10.4049/jimmunol.0803743, 19494303.
56. Moraes TJ, Martin R, Plumb JD, Vachon E, Cameron CM, Danesh A, Kelvin DJ, Ruf W, Downey GP. Role of PAR2 in murine pulmonary pseudomonal infection. Am J Physiol Lung Cell Mol Physiol 2008, 294(2):L368-377.
57. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 2004, 14(3):289-301. 10.1016/S1097-2765(04)00236-9, 15125833.
58. Sakurai H, Singhirunnusorn P, Shimotabira E, Chino A, Suzuki S, Koizumi K, Saiki I. TAK1-mediated transcriptional activation of CD28-responsive element and AP-1-binding site within the IL-2 promoter in Jurkat T cells. FEBS Lett 2005, 579(29):6641-6646. 10.1016/j.febslet.2005.10.059, 16293250.
59. Wojtkiewicz PW, Phelps CJ, Hurley DL. Transcript abundance in mouse pituitaries with altered growth hormone expression quantified by reverse transcriptase polymerase chain reaction implicates transcription factor Zn-16 in gene regulation in vivo. Endocrine 2002, 18(1):67-74. 10.1385/ENDO:18:1:67, 12166626.
60. Chattopadhyay A, Gray LR, Patton LL, Caplan DJ, Slade GD, Tien HC, Shugars DC. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons. Infect Immun 2004, 72(4):1956-1963. 10.1128/IAI.72.4.1956-1963.2004, 375171, 15039315.
61. Moreau T, Baranger K, Dade S, Dallet-Choisy S, Guyot N, Zani ML. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family. Biochimie 2008, 90(2):284-295. 10.1016/j.biochi.2007.09.007, 17964057.
62. Nishimura J, Saiga H, Sato S, Okuyama M, Kayama H, Kuwata H, Matsumoto S, Nishida T, Sawa Y, Akira S, et al. Potent antimycobacterial activity of mouse secretory leukocyte protease inhibitor. J Immunol 2008, 180(6):4032-4039.
63. Sehnert B, Cavcic A, Bohm B, Kalden JR, Nandakumar KS, Holmdahl R, Burkhardt H. Antileukoproteinase: modulation of neutrophil function and therapeutic effects on anti-type II collagen antibody-induced arthritis. Arthritis Rheum 2004, 50(7):2347-2359. 10.1002/art.20339, 15248236.
64. Sehnert B, Gierer P, Ibrahim S, Kuhl A, Voll R, Nandakumar KS, Holmdahl R, Hallmann R, Vollmar B, Burkhardt H. Modulation of granulocyte-endothelium interactions by antileukoproteinase: inhibition of anti-type II collagen antibody-induced leukocyte attachment to the synovial endothelium. Arthritis Res Ther 2006, 8(4):R95. 10.1186/ar1973, 1779410, 16776851.
65. Ward PA, Lentsch AB. Endogenous regulation of the acute inflammatory response. Mol Cell Biochem 2002, 234-235(1-2):225-228.
66. Weldon S, McGarry N, Taggart CC, McElvaney NG. The role of secretory leucoprotease inhibitor in the resolution of inflammatory responses. Biochem Soc Trans 2007, 35(Pt 2):273-276.
67. Wex T, Treiber G, Nilius M, Vieth M, Roessner A, Malfertheiner P. Helicobacter pylori-mediated gastritis induces local downregulation of secretory leukocyte protease inhibitor in the antrum. Infect Immun 2004, 72(4):2383-2385. 10.1128/IAI.72.4.2383-2385.2004, 375164, 15039364.
68. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, Lacomis L, Erdjument-Bromage H, Tempst P, Wright CD, et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 2002, 111(6):867-878. 10.1016/S0092-8674(02)01141-8, 12526812.
69. Py B, Basmaciogullari S, Bouchet J, Zarka M, Moura IC, Benhamou M, Monteiro RC, Hocini H, Madrid R, Benichou S. The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane. PLoS ONE 2009, 4(3):e5006. 10.1371/journal.pone.0005006, 2659420, 19333378.
70. Weldon S, Taggart CC. Innate host defense functions of secretory leucoprotease inhibitor. Exp Lung Res 2007, 33(10):485-491. 10.1080/01902140701756547, 18075823.
71. Nakamura A, Mori Y, Hagiwara K, Suzuki T, Sakakibara T, Kikuchi T, Igarashi T, Ebina M, Abe T, Miyazaki J, et al. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J Exp Med 2003, 197(5):669-674. 10.1084/jem.20021824, 2193830, 12615907.
72. Henriksen PA, Hitt M, Xing Z, Wang J, Haslett C, Riemersma RA, Webb DJ, Kotelevtsev YV, Sallenave JM. Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. J Immunol 2004, 172(7):4535-4544.
73. Marino R, Thuraisingam T, Camateros P, Kanagaratham C, Xu YZ, Henri J, Yang J, He G, Ding A, Radzioch D. Secretory leukocyte protease inhibitor plays an important role in the regulation of allergic asthma in mice. J Immunol 2011, 186(7):4433-4442. 10.4049/jimmunol.1001539, 3104396, 21335488.
74. Odaka C, Mizuochi T, Yang J, Ding A. Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response. J Immunol 2003, 171(3):1507-1514.
75. Yang J, Zhu J, Sun D, Ding A. Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function. Biochim Biophys Acta 2005, 1745(3):310-317. 10.1016/j.bbamcr.2005.07.006, 16112212.
76. Mahajan MA, Murray A, Samuels HH. NRC-interacting factor 1 is a novel cotransducer that interacts with and regulates the activity of the nuclear hormone receptor coactivator NRC. Mol Cell Biol 2002, 22(19):6883-6894. 10.1128/MCB.22.19.6883-6894.2002, 134037, 12215545.
77. Garapaty S, Mahajan MA, Samuels HH. Components of the CCR4-NOT complex function as nuclear hormone receptor coactivators via association with the NRC-interacting Factor NIF-1. J Biol Chem 2008, 283(11):6806-6816. 10.1074/jbc.M706986200, 18180299.
78. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19(2):185-193. 10.1093/bioinformatics/19.2.185, 12538238.
79. Alberts R, Fu J, Swertz MA, Lubbers LA, Albers CJ, Jansen RC. Combining microarrays and genetic analysis. Brief Bioinform 2005, 6(2):135-145. 10.1093/bib/6.2.135, 15975223.
80. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3. Article3.
81. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5(10):R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
82. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics 2007, 23(2):257-258. 10.1093/bioinformatics/btl567, 17098774.